| Long-term outcomes and responses to retreatment in patients with melanoma treated with PD-1 blockade A Betof Warner, JS Palmer, AN Shoushtari, DA Goldman, KS Panageas, ... Journal of Clinical Oncology 38 (15), 1655-1663, 2020 | 175 | 2020 |
| Effect of osimertinib and bevacizumab on progression-free survival for patients with metastatic EGFR-mutant lung cancers: a phase 1/2 single-group open-label trial AY Helena, AJ Schoenfeld, A Makhnin, R Kim, H Rizvi, D Tsui, C Falcon, ... JAMA oncology 6 (7), 1048-1054, 2020 | 132 | 2020 |
| Dual-energy CT angiography for detection of pulmonary emboli: incremental benefit of iodine maps EK Weidman, AJ Plodkowski, DF Halpenny, SA Hayes, R Perez-Johnston, ... Radiology 289 (2), 546-553, 2018 | 119 | 2018 |
| Comparison of CT volumetric measurement with RECIST response in patients with lung cancer SA Hayes, MC Pietanza, D O’Driscoll, J Zheng, CS Moskowitz, MG Kris, ... European journal of radiology 85 (3), 524-533, 2016 | 85 | 2016 |
| Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements? DF Halpenny, GJ Riely, S Hayes, H Yu, J Zheng, CS Moskowitz, ... Lung cancer 86 (2), 190-194, 2014 | 73 | 2014 |
| Non-contrast CT at comparable dose to an abdominal radiograph in patients with acute renal colic; impact of iterative reconstruction on image quality and diagnostic performance PD McLaughlin, KP Murphy, SA Hayes, K Carey, J Sammon, L Crush, ... Insights into imaging 5, 217-230, 2014 | 72 | 2014 |
| Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging AM Litvak, K Woo, S Hayes, J Huang, A Rimner, CS Sima, AL Moreira, ... Journal of Thoracic Oncology 9 (12), 1810-1815, 2014 | 71 | 2014 |
| Postoperative complications after thoracic surgery for lung cancer JA Rotman, AJ Plodkowski, SA Hayes, PM de Groot, JAO Shepard, ... Clinical Imaging 39 (5), 735-749, 2015 | 68 | 2015 |
| Preoperative computed tomography findings predict surgical resectability of thymoma SA Hayes, J Huang, AJ Plodkowski, J Katzen, J Zheng, CS Moskowitz, ... Journal of Thoracic Oncology 9 (7), 1023-1030, 2014 | 45 | 2014 |
| Twice weekly pulse and daily continuous‐dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases KC Arbour, MG Kris, GJ Riely, A Ni, K Beal, M Daras, SA Hayes, ... Cancer 124 (1), 105-109, 2018 | 33 | 2018 |
| Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy D Halpenny, CA Ridge, S Hayes, J Zheng, CS Moskowitz, A Rimner, ... Clinical imaging 39 (2), 254-258, 2015 | 27 | 2015 |
| Imaging appearances of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia PJ Foran, SA Hayes, DJ Blair, MF Zakowski, MS Ginsberg Clinical Imaging 39 (2), 243-246, 2015 | 25 | 2015 |
| Cardiothoracic manifestations of Erdheim-Chester disease JP Das, L Xie, CC Riedl, SA Hayes, MS Ginsberg, DF Halpenny The British Journal of Radiology 92 (1104), 20190473, 2019 | 22 | 2019 |
| Radiographic predictors of resectability in thymic carcinoma SA Hayes, J Huang, JG Pernicka, J Cunningham, J Zheng, CS Moskowitz, ... The Annals of thoracic surgery 106 (1), 242-248, 2018 | 19 | 2018 |
| Clinical consequences of an indeterminate CT pulmonary angiogram in cancer patients SA Hayes, GA Soff, EC Zabor, CS Moskowitz, CC Liu, MS Ginsberg Clinical imaging 38 (5), 637-640, 2014 | 17 | 2014 |
| Communication of unexpected and significant findings on chest radiographs with an automated PACS alert system SA Hayes, M Breen, PD McLaughlin, KP Murphy, MT Henry, MM Maher, ... Journal of the American College of Radiology 11 (8), 791-795, 2014 | 17 | 2014 |
| Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor J Luo, A Makhnin, Y Tobi, L Ahn, SA Hayes, A Iqbal, K Ng, ME Arcila, ... JCO Precision Oncology 5, 55-64, 2021 | 16 | 2021 |
| Pilot Study of Dacomitinib for Patients With Metastatic EGFR-Mutant Lung Cancers With Disease Progression After Initial Treatment With Osimertinib NJ Choudhury, A Makhnin, YY Tobi, RM Daly, IR Preeshagul, AN Iqbal, ... JCO Precision Oncology 5, 695-700, 2021 | 14 | 2021 |
| A phase 1/2 study of osimertinib and bevacizumab as initial treatment for patients with metastatic EGFR-mutant lung cancers. HA Yu, R Kim, A Makhnin, LSH Ahn, A Ni, SA Hayes, RJ Young, GJ Riely, ... Journal of Clinical Oncology 37 (15_suppl), 9086-9086, 2019 | 13 | 2019 |
| Prognostic significance of supraclavicular lymphadenopathy in patients with high-grade serous ovarian cancer P Cybulska, SA Hayes, A Spirtos, MJ Rafizadeh, OT Filippova, M Leitao, ... International Journal of Gynecological Cancer 29 (9), 1377-1380, 2019 | 12 | 2019 |